Question Is a multicomponent vaccine against seasonal influenza and SARS-CoV-2 (mRNA-1083) immunogenic and well-tolerated in adults 50 years and older?

Findings In this phase 3 study, mRNA-1083 elicited noninferior immune responses against standard care immunization: licensed standard-dose or high-dose seasonal influenza vaccine (A/H1N1, A/H3N2, B/Victoria, B/Yamagata) coadministered with licensed SARS-CoV-2 (Omicron XBB.1.5) vaccine. The multicomponent vaccine mRNA-1083 had an acceptable tolerability and safety profile.

Meaning mRNA-1083 was demonstrated to be at least as immunogenic as recommended standard care vaccines against both seasonal influenza and COVID-19 and well-tolerated in adults 50 years and older.

  • recursive_recursion they/them@lemmy.ca
    link
    fedilink
    English
    arrow-up
    0
    ·
    edit-2
    23 days ago

    Reading the post, linked article, and your comment I’m wondering: aren’t you guys on the same side (stating that vaccines work)?

    I could be wrong but I don’t see @[email protected] disputing the efficacy of vaccines and is in fact doing the opposite by providing evidence that vaccines do work.